Assignee
SIGNAL PHARM INC
US·34 granted patents·8 pending applications·834 citations·filing 1992–2006
Top patents by PatentIndex Score
42 records- 0193US6897231B2Indazole derivatives as JNK inhibitors and compositions and methods related theretoSIGNAL PHARM INC·Filed 2001·Granted May 24, 2005·62 cites·26 claims
- 0293US5939421AQuinazoline analogs and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1997·Granted Aug 17, 1999·57 cites·25 claims
- 0391US6331562B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Dec 18, 2001·63 cites·63 claims
- 0491US6291456B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Sep 18, 2001·62 cites·78 claims
- 0591US5811428APyrimidine carboxamides and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1995·Granted Sep 22, 1998·69 cites·27 claims
- 0690US5935966APyrimidine carboxylates and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1997·Granted Aug 10, 1999·63 cites·24 claims
- 0788US6593322B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Jul 15, 2003·31 cites·26 claims
- 0887US6436923B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Aug 20, 2002·26 cites·50 claims
- 0986US6620838B1Benzopyrazone compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM INC·Filed 2002·Granted Sep 16, 2003·24 cites·33 claims
- 1083US6576437B2Stimulus-inducible protein kinase complex and methods of use thereforSIGNAL PHARM INC·Filed 2001·Granted Jun 10, 2003·13 cites·10 claims
- 1182US6686351B2Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2002·Granted Feb 3, 2004·15 cites·18 claims
- 1280US6656713B2Compounds and methods for modulating activation of NF-κBSIGNAL PHARM INC·Filed 2001·Granted Dec 2, 2003·14 cites·7 claims
- 1380US6372739B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2001·Granted Apr 16, 2002·13 cites·20 claims
- 1480US5852028APyrimidine carboxylates and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1995·Granted Dec 22, 1998·29 cites·39 claims
- 1579US5830651AHuman oligodendroglial progenitor cell lineSIGNAL PHARM INC·Filed 1995·Granted Nov 3, 1998·78 cites·29 claims
- 1677US5948885AMitogen-activated protein kinase p38-2 and methods of use thereforSIGNAL PHARM INC·Filed 1996·Granted Sep 7, 1999·32 cites·1 claims
- 1772US6258579B1Stimulus-inducible protein kinase complex and methods of use thereforSIGNAL PHARM INC·Filed 1997·Granted Jul 10, 2001·28 cites·4 claims
- 1872US5932425ACompositions and methods for modulating cellular NF-κB activationSIGNAL PHARM INC·Filed 1997·Granted Aug 3, 1999·35 cites·7 claims
- 1970US6677130B1Mitogen-activated protein kinase p38-2 and methods of use thereforSIGNAL PHARM INC·Filed 2000·Granted Jan 13, 2004·2 cites·5 claims
- 2070US5972674AStimulus-inducible protein kinase complex and methods of use thereforSIGNAL PHARM INC·Filed 1996·Granted Oct 26, 1999·18 cites·2 claims
- 2166US2005255094A1Mitogen-activated protein kinase kinase MEK6 and methods of use thereforSIGNAL PHARM INC·Filed 2004·Application pending·0 cites
- 2266US2006110799A1Mitogen-activated protein kinase kinase MEK6 and methods of use thereofSIGNAL PHARM INC·Filed 2006·Application pending·0 cites
- 2364US6835567B1PNS cell lines and methods of use thereforSIGNAL PHARM INC·Filed 1998·Granted Dec 28, 2004·15 cites·31 claims
- 2464US6150372APyridopyrimidine analogs and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1999·Granted Nov 21, 2000·8 cites·25 claims
- 2564US2004235112A1Mitogen-activated protein kinase kinase MEK6 and methods of use thereofSIGNAL PHARM INC·Filed 2004·Application pending·0 cites
- 2662US6225122B1Human spinal cord cell lines and methods of use thereforSIGNAL PHARM INC·Filed 1998·Granted May 1, 2001·16 cites·15 claims
- 2762US6074862AMitogen-activated protein kinase kinase MEK6 and variants thereofSIGNAL PHARM INC·Filed 1995·Granted Jun 13, 2000·17 cites·2 claims
- 2861US2003175928A1Mitogen-activated protein kinase MEK6 and methods of use thereforSIGNAL PHARM INC·Filed 2003·Application pending·0 cites
- 2960US2005124007A1Human mesencephalon cell lines and methods of use thereforSIGNAL PHARM INC·Filed 2004·Application pending·0 cites
- 3060US2005095701A1PNS cell lines and methods of use thereforSIGNAL PHARM INC·Filed 2004·Application pending·0 cites
- 3158US7202049B2Mitogen-activated protein kinase p38-2 and methods of use thereforSIGNAL PHARM INC·Filed 2002·Granted Apr 10, 2007·0 cites·6 claims
- 3254US2003054528A1Mitogen-activated protein kinase p38-2 and methods of use thereforSIGNAL PHARM INC·Filed 2002·Application pending·0 cites
- 3353US5981188AMethod for identifying agents that modulate transcription of human cytomegalovirus polymeraseSIGNAL PHARM INC·Filed 1997·Granted Nov 9, 1999·8 cites·2 claims
- 3447US5945276AReporter cell line system for detecting cytomegalovirus and identifying modulators of viral gene expressionSIGNAL PHARM INC·Filed 1996·Granted Aug 31, 1999·8 cites·8 claims
- 3547US2003119072A1Methods for modulating signal transduction mediated by TGF-beta related proteinsSIGNAL PHARM INC·Filed 2002·Application pending·0 cites
- 3643US6326480B1Antisense reporter system for assaying RNA virus replicationSIGNAL PHARM INC·Filed 1999·Granted Dec 4, 2001·7 cites·6 claims
- 3739US6444455B1Mitogen-activated protein kinase P38-2 and methods of use thereforSIGNAL PHARM INC·Filed 1999·Granted Sep 3, 2002·2 cites·11 claims
- 3837US6063578ADual reporter system and methods of use thereforSIGNAL PHARM INC·Filed 1998·Granted May 16, 2000·10 cites·40 claims
- 3934US6521601B1Method and composition for inhibition of viral replicationSIGNAL PHARM INC·Filed 1992·Granted Feb 18, 2003·6 cites·10 claims
- 4032US6413720B1Method for the affinity isolation of newly synthesized RNASIGNAL PHARM INC·Filed 1999·Granted Jul 2, 2002·2 cites·14 claims
- 4130US5910411AMethod for identifying agents that modulate transcription of human cytomegalovirus polymeraseSIGNAL PHARM INC·Filed 1996·Granted Jun 8, 1999·0 cites·8 claims
- 4228US5932618AAnti-viral agents and methods relating to the use thereofSIGNAL PHARM INC·Filed 1996·Granted Aug 3, 1999·1 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when SIGNAL PHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →